Companies » Company Overview » Glaxosmithkline Pharma Ltd.
 
 

Glaxosmithkline Pharma Ltd.

  • BSE: 500660
  • Sector: Health care
  • NSE: GLAXO
  • ISIN Code: INE159A01016
  • BSE

    LIVE

    15:46 | 29 May

  • 3226.10
  • 40.40
    (1.27%)
  • Open
    3201.90
  • HIGH
    3239.00
  • LOW
    3188.80
  • NSE

    LIVE

    15:45 | 29 May

  • 3228.10
  • 27.25
    (0.85%)
  • Open
    3195.00
  • HIGH
    3240.00
  • LOW
    3185.00
 
bse
15:46 PM,29th May 2015
3226.10
40.40 (1.27%)
Previous Close 3185.70
Volume 742
52-Week high 3550.00
52-Week low 2351.60
P/E 68.36
Mkt Cap.(Rs cr) 27325
Bid Price 0.00
Bid Quantity 0.00
Offer Price 3226.10
Offer Quantity 1.00
NSE
15:45 PM,29th May 2015

3228.10
27.25 (0.85%)
Bse
15:46 PM,29th May 2015

3226.10
40.40 (1.27%)
nse
15:45 PM,29th May 2015
3228.10
27.25 (0.85%)
Previous Close 3200.85
Volume 8064
52-Week high 3550.00
52-Week low 2415.25
P/E 68.36
Mkt Cap.(Rs cr) 27325
Bid Price 3228.10
Bid Quantity 59.00
Offer Price 0.00
Offer Quantity 0.00

Glaxosmithkline Pharma Ltd. (GLAXO) - Company Information

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, c... [More]

Key Fundamentals
Market Cap (Rs cr) 27,325
EPS - TTM (Rs)

[*S]

47.19
P/E Ratio (x)

[*S]

68.36
Face Value (Rs) 10
Latest Dividend (%) 625.00
Latest Dividend Date 23 Jul 2015
Dividend Yield (%) 1.94
Book Value / Share (Rs)

[*S]

218.61
P/B Ratio (x)

[*S]

14.76
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
3188.80
3239.00
Week Low/High
3145.00
3250.00
Month Low/High
3038.05
3325.00
YEAR Low/High
2351.60
3550.00
All TIME Low/High
25.75
3550.00
Peer Group
Company Last Change(%)
Cipla 650.45 1.10
Aurobindo Pharma 1374.95 5.43
Cadila Health. 1880.75 0.96
Glaxosmit Pharma 3226.10 0.85
Glenmark Pharma. 877.15 2.32
Divi's Lab. 1819.15 0.86
Torrent Pharma. 1214.90 -1.68
Returns
Period Glaxosmit Pharma Sensex NIFTY
1 Week 0.95% -0.46% -0.30%
1 Month 3.26% 2.21% 2.35%
3 Month 3.68% -5.22% -5.26%
6 Month 10.11% -3.02% -1.80%
1 Year 31.59% 14.83% 16.56%
3 Year 61.97% 69.29% 69.01%
Period Glaxosmit Pharma Sensex NIFTY
1 Week 1.13% -0.46% -0.30%
1 Month 2.80% 2.21% 2.35%
3 Month 3.82% -5.22% -5.26%
6 Month 10.03% -3.02% -1.80%
1 Year 31.58% 14.83% 16.56%
3 Year 62.38% 69.29% 69.01%
SHAREHOLDER VOTING RECOMMENDATION
Date Advisory Report
24/02 IIAS PDF Icon
Financial Results
Particulars (Rs cr) Mar 2015 Mar 2014 %Chg
Net Sales 620.31 609.85 1.72
Other Income 40.48 44.88 -9.8
Total Income 660.79 654.73 0.93
Total Expenses 500.35 502.25 -0.38
Operating Profit 160.44 152.48 5.22
Net Profit 102.85 96.54 6.54
Equity Capital 84.7 84.7 -
SHAREHOLDING PATTERN
As on Mar 2015
Research Reports
Date Broker Action Price Report
13/08 Angel Broking Neutral 2513 PDF Icon
28/04 Angel Broking Neutral 2450 PDF Icon
21/04 Centrum Sell 2492 PDF Icon
13/11 Centrum Sell 2470 PDF Icon
Company information
Chairman : D S Parekh
Vice Chairman : V Thyagarajan
Managing Director : H B Joshipura
Director : R R Bajaaj
Director : N Kaviratne
Director : P V Nayak
Executive Director (HR) : R C Sequeira
Director : D Sundaram
Company Secretary : A A Nadkarni
Director : P V Bhide
Executive Director (Technical) : Raju Krishnaswamy
Director : A N Roy
Non-Exec. & Independent Dir. : Anjali P Bansal
Non Executive Director : Regis Simard
AUDITOR: Price Waterhouse & Co
IND NAME: Pharmaceuticals - Multinational
HOUSE NAME: MNC Associate - Glaxo
Registered office
GSK House, Dr Annie Besant Road Worli,
Mumbai,Maharashtra-400030
Ph: 91-022-24959595
E-mail: ajay.a.nadkarni@gsk.com
URL: http://www.gsk-india.com

Quick Links

 
Quick Links for Glaxosmithkline Pharma

Back to Top